Back to Search
MAUREEN ZAKOWSKI, MD
MD
Anatomic Pathology Physician
NPI: 1619957578IndividualAccepts Medicare
Specialties, Licenses & Credentials
Anatomic Pathology PhysicianPrimary
Pathology — Anatomic Pathology
Code: 207ZP0101X
175108(NY)
CMS Specialties
PrimaryPATHOLOGY
Education
OTHER
Class of 1984
Research & Publications (20)
Morphologic features of adenocarcinoma of the lung predictive of response to the epidermal growth factor receptor kinase inhibitors erlotinib and gefitinib.
PMID 19260752·Arch Pathol Lab Med·2009
8-other
An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors.
PMID 19525976·Oncogene·2009
8-other
Prognostic and therapeutic implications of EGFR and KRAS mutations in resected lung adenocarcinoma.
PMID 18303429·J Thorac Oncol·2008
8-other
Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study.
PMID 18641660·Nat Med·2008
4-observational
The impact of lymph node station on survival in 348 patients with surgically resected malignant pleural mesothelioma: implications for revision of the American Joint Committee on Cancer staging system.
PMID 18805259·J Thorac Cardiovasc Surg·2008
8-other
Molecular characteristics of bronchioloalveolar carcinoma and adenocarcinoma, bronchioloalveolar carcinoma subtype, predict response to erlotinib.
PMID 18349398·J Clin Oncol·2008
3-trial
EGFR mutations in lung adenocarcinomas: clinical testing experience and relationship to EGFR gene copy number and immunohistochemical expression.
PMID 18403609·J Mol Diagn·2008
8-other
Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients.
PMID 18329481·J Thorac Cardiovasc Surg·2008
4-observational
Evidence-based pathology and the pathologic evaluation of thymomas: the World Health Organization classification can be simplified into only 3 categories other than thymic carcinoma.
PMID 18442102·Cancer·2008
1-meta
Molecularly tailored adjuvant chemotherapy for resected non-small cell lung cancer: a time for excitement and equipoise.
PMID 18166846·J Thorac Oncol·2008
6-review
Epidermal growth factor receptor signaling in adenocarcinomas with bronchioloalveolar components.
PMID 18154814·Ann Thorac Surg·2008
8-other
Evidence-based pathology and the pathologic evaluation of thymomas: transcapsular invasion is not a significant prognostic feature.
PMID 18517274·Arch Pathol Lab Med·2008
1-meta
Prognostic factors in the treatment of malignant pleural mesothelioma at a large tertiary referral center.
PMID 17909360·J Thorac Oncol·2007
3-trial
Mutational analysis of EGFR and related signaling pathway genes in lung adenocarcinomas identifies a novel somatic kinase domain mutation in FGFR4.
PMID 17487277·PLoS One·2007
8-other
Development of new mouse lung tumor models expressing EGFR T790M mutants associated with clinical resistance to kinase inhibitors.
PMID 17726540·PLoS One·2007
7-preclinical
Bronchioloalveolar carcinoma and lung adenocarcinoma: the clinical importance and research relevance of the 2004 World Health Organization pathologic criteria.
PMID 17409995·J Thorac Oncol·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1468 MADISON AVE, 15TH FLOOR, BOX 1194
NEW YORK, NY 10029 - Phone
- (212) 241-8014
Quick Facts
- NPI
- 1619957578
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 42
- Publications
- 20
Are you this provider?
Claim Your Profile